LBX Pharmacy Chain Joint Stock Company (SHA:603883)
12.69
-0.12 (-0.94%)
Sep 16, 2026, 3:00 PM CST
SHA:603883 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 22,460 | 22,237 | 22,358 | 22,437 | 20,176 | 15,696 |
Revenue Growth | 1.21% | -0.54% | -0.36% | 11.21% | 28.54% | 12.38% |
Gross Profit Gross Profit Growth | 7,178 | 7,173 | 7,412 | 7,280 | 6,425 | 5,037 |
Operating Income Operating Income Growth | 1,179 | 1,091 | 1,165 | 1,469 | 1,371 | 1,027 |
Net Income Net Income Growth | 430.77 | 381.85 | 519.06 | 929.02 | 784.96 | 669.24 |
Earnings Per Share EPS Growth | 0.57 | 0.50 | 0.68 | 1.23 | 1.05 | 0.95 |
EPS Growth | 4.72% | -26.47% | -44.71% | 17.57% | 10.57% | 5.20% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Wholesale Division Wholesale Division Growth | 12,311 |
Inter Segment Offset Inter Segment Offset Growth | -9,632 |
Others Others Growth | 442.02 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 19,115 |
Total Total Growth | 22,237 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,318 | 2,380 | 2,416 | 2,008 | 2,425 | 1,419 |
Total Debt Total Debt Growth | 3,945 | 4,564 | 5,781 | 5,033 | 5,456 | 6,021 |
Net Cash (Debt) Net Cash Growth | -1,627 | -2,184 | -3,365 | -3,025 | -3,031 | -4,602 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.14 | -2.86 | -4.41 | -4.00 | -4.04 | -6.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,921 | 3,143 | 2,026 | 2,730 | 2,314 | 2,298 |
Capital Expenditures CapEx Growth | -184.99 | -253.44 | -507.5 | -620.87 | -308.44 | -478.61 |
Free Cash Flow Free Cash Flow Growth | 2,736 | 2,889 | 1,519 | 2,109 | 2,006 | 1,820 |
Free Cash Flow Growth | 6.52% | 90.21% | -27.98% | 5.14% | 10.23% | 72.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.96% | 32.26% | 33.15% | 32.45% | 31.84% | 32.09% |
Operating Margin | 5.25% | 4.91% | 5.21% | 6.55% | 6.80% | 6.54% |
Pretax Margin | 3.78% | 3.40% | 4.10% | 6.27% | 5.99% | 6.13% |
Profit Margin | 1.92% | 1.72% | 2.32% | 4.14% | 3.89% | 4.26% |
FCF Margin | 12.18% | 12.99% | 6.79% | 9.40% | 9.94% | 11.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.410 | 0.410 | 0.411 | 0.508 | 0.385 | 0.296 |
Dividend Per Share Growth | 159.09% | -0.17% | -19.11% | 32.01% | 30.02% | 42.83% |
Dividend Yield | 3.04% | 2.90% | 2.66% | 2.45% | 1.39% | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.59 | 29.41 | 23.98 | 18.82 | 30.16 | 29.97 |
Forward PE | 17.22 | 18.86 | 13.87 | 17.57 | 31.58 | 27.90 |
P/FCF Ratio | 3.55 | 3.89 | 8.19 | 8.29 | 11.80 | 11.02 |
PS Ratio | 0.43 | 0.51 | 0.56 | 0.78 | 1.17 | 1.28 |